EVENT PROGRAMME
PROGRAM-AT-A-GLANCE
11 November 2022
AFCC 2022 Convocation and Opening Ceremony
Sukaman Lecture
- The Heart of our Pandemic
CV Imaging in the Evaluation of LV Dysfunction
- Assessment of LV Dysfunction in Diabetes: What are My Options?
- LV Function Analysis Beyond EF: Echo Perspective
- CMR Imaging in LV Dysfunction: How Useful?
Preventive Cardiology
- What is the Effective and Safe Goal LDL for the Asians? Are We the Same as the Caucasians?
- Future Therapies for Lipid Lowering: Injectables
- CVD Begins in Childhood
RF/RHD and Kawasaki Disease
- Potential CV Sequelae of KD in Adults
- Knowledge and Practice Gaps in the RF/RHD Programs
- Breakthroughs in RHD Tertiary Prevention
Heart Failure
- Should We Start HF Medications in Stage B Heart Failure?
- Worsening Heart Failure Phase in Worsening Renal Function – Is There A Roadmap?
- Shock at a Glance: Understanding Heart Failure - Cardiogenic shock (HF-CS)
1st CPR Summit
- The Future of CPR: from Human Intervention to Artificial Intelligence
- Getting High on Drugs: Review and Updates on Resuscitation Medications
- Mission Impossible: Trade Secrets for Very Difficult ACLS and Cardiac Arrest Scenarios
Asia Pacific Resuscitation Symposium: The Best Practices in Resuscitation and Resuscitation Education (Panel Discussion)
- National Resuscitation Guidelines and National Policies on Public Access Defibrillation
- Changes and Challenges in CPR and CPR Training during The Pandemic and Evolution in the New Normal
- Pediatric Resuscitation in the ASEAN Region
The Global Resuscitation Alliance (GRA): An Asian Perspective
- Defining GRA: Steps to CPR-Readiness
- Implementing the GRA: Best Models and Practices in the Asian Region
- GRA: Challenges in Developing Countries
Multimodality Imaging of LVH / Cardiomyopathy
-
Beyond Echoes of the Heart: Clinical Indications for CT and MRI
-
CMR in Hypertensive LV Hypertrophy
-
Speckle Tracking Echocardiography (Strain) for Refined Differentiation of Cardiomyopathies
Industry Symposium Lectures
- Is there a Role for SALT2i in Heart Failure across the EF Spectrum
- Perspectives and Emerging Evidence: Deep Dive into the Cardio-Renal Connection
- Simplifying the Treatment Approach Across the Full Spectrum of Heart Failure
- The Role of Edoxaban in Elderly Frail Patients
11 November 2022
12 November 2022
AFC ESC Joint Session
-
CHIP Intervention: Issues & An ASEAN Perspective
-
Sex Specific Considerations for TAVI Management in Women
Hypertension
- Hypertension Beyond Numbers
- Updates on Hypertension in the Philippines (PRESYON 4 and the 2020 Phil HPN Guidelines)
- Revisiting Renal Denervation for the Treatment of Resistant Hypertension
Imaging in Structural Heart Disease
- Revisiting of Guidelines for TEE Screening for Structural Heart Intervention
- Imaging the “Forgotten Valve”: 2D and 3D Imaging of the Tricuspid Valve and Tricuspid Valve Interventions
- Intracardiac Echocardiography (ICE) and Its Application for Interventional Cardiology. Will this Become Mainstream?
Women’s Health
- What is the Current Status of CV Health in Women? Are They Included Already in Trials/Research for Risks Reduction in ASHD?
- MINOCA / Broken Heart Syndrome… Why Are They Common in Women?
- Microvascular Heart Disease in Women?
CAD
- Sensi, Speci and Everything in Between: Accuracy and Reliability of Various Noninvasive Imaging Tools for Ischemic and Coronary Artery Disease
- Establishing Rule-Out Protocol in Acute Chest Pain
- Optimal Medical Therapy for Chronic Coronary Syndromes: How Far is Optimum Until Revascularization?
Interventional Cardiology
- PCI of the OHCA: To Do or Not To Do
- Intravascular Imaging / Physiology: Guiding PCI to Improve Outcomes
- Transcatheter Valvular Heart Disease Interventions: What’s In? What’s Out? What’s Next?
CV Oncology
- Arrhythmias and QT Prolongation in Cancer Therapy: Surveillance and Management
- Prostate Cancer and Cardiovascular Disease
- Progressive Vasculopathy in Radiation Therapy in Cancer Patients: Surveillance, Treatment and Prevention
Vascular Conundrums
- Approach to the Management of Ascending and Aortic Arch Conditions
- VTE in Hypercoagulable States
- Critical Limb Ischemia Management
CV Surgery
- Effect of COVID on Cardiac Surgery in the Philippines
- Minimally Invasive Cardiac Surgery (MICS) Strategies for Coronary Artery Disease
- How we treat Mechanical complications of Acute MI focus on Post Infarct Ventricular Septal Rupture
Industry Symposium Lectures
-
Spotlight on Heart Failure: The Role of Dapagliflozin in Patients with Heart Failure Across the Range of Ejection Fraction
-
Sugar and Stroke: Protecting Patients with Atrial Fibrillation and Diabetes Mellitus
-
Defusing a Time Bomb: Managing Hypertension in the Not-So-Young
-
Sugar and Stroke: Protecting Patients with Atrial Fibrillation and Diabetes Mellitus
-
Japanese Experience with Heated Tobacco Products
-
Risk Reduction in Cardiovascular Disease in Smokers - An Evidence Based Approach
-
Brief Discussion on Vietnam Perspective
13 November 2022
AFC - APSC Joint Session
- Stroke Prevention in Atrial Fibrillation: Asian Perspective
- MitraClip for FMR: It is Ever Too Early?
EPS
- Evolution of Pacing Strategies: From Heart Rate Assurance to Preservation of A-V and LV Synchrony (Physiologic pacing = His / LBB Pacing)
- Catheter Ablation in Atrial Fibrillation Optimal Timing and Patient Selection
- Opportunistic Screening for AF Among Patients at Risk: Use of Mobile Single Lead ECG Implantable Loop Recorders, ECG Watches
Sports Cardiology / Cardiac Rehab
- 2021 Asia-Pacific Guidelines on Sports Participation Screening
- Holistic Stress Management for Cardiac Rehabilitation Patients
- Sharing of Best Practices: Remote / Tele Cardiac Rehabilitation Programs
Congenital Heart Disease
- Impact of Risk Stratification Scoring Systems/Models' in Post Intervention/Surgery Outcome
- Continuum of Care in Complex CHD
- Perioperative/Procedural Management of Patients with CHD-PAH
Myocardial Diseases
- Cardiomyopathy in COVID-19 Infection: Clinical Evaluation and Management
- Risk of Myocarditis After COVID-19 mRNA Vaccination: An Evidence-based Review
- Advances in the Treatment of Obstructive Hypertrophic Cardiomyopathy – Targeted Therapy with Mavacamten
Closing Ceremonies
Fellowship Night
13 November 2022
